Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2018 | -2 Million USD | 47.33% |
| 2017 | -3.8 Million USD | 16.16% |
| 2016 | -4.54 Million USD | -15.51% |
| 2015 | -3.93 Million USD | -24.85% |
| 2014 | -3.14 Million USD | -15.25% |
| 2013 | -2.73 Million USD | -4.79% |
| 2012 | -2.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2019 Q2 | -407.46 USD | -2.09% |
| 2019 Q3 | -403.21 USD | 1.04% |
| 2019 Q1 | -399.13 USD | 43.19% |
| 2018 Q4 | -702.58 USD | -229.9% |
| 2018 FY | -2 Million USD | 47.33% |
| 2018 Q1 | -754.67 USD | 38.64% |
| 2018 Q2 | -375.73 USD | 50.21% |
| 2018 Q3 | -212.97 USD | 43.32% |
| 2017 Q3 | -1039.43 USD | 24.7% |
| 2017 Q2 | -1380.37 USD | -611.14% |
| 2017 Q1 | -194.11 USD | 86.11% |
| 2017 FY | -3.8 Million USD | 16.16% |
| 2017 Q4 | -1229.95 USD | -18.33% |
| 2016 Q4 | -1397.17 USD | -46.79% |
| 2016 Q3 | -951.80 USD | -70.56% |
| 2016 FY | -4.54 Million USD | -15.51% |
| 2016 Q2 | -558.04 USD | 68.59% |
| 2016 Q1 | -1776.40 USD | 5.73% |
| 2015 FY | -3.93 Million USD | -24.85% |
| 2015 Q4 | -1884.46 USD | -316.37% |
| 2015 Q3 | -452.59 USD | 36.93% |
| 2015 Q2 | -717.58 USD | 5.2% |
| 2015 Q1 | -756.97 USD | 3.17% |
| 2014 FY | -3.14 Million USD | -15.25% |
| 2014 Q3 | -748.17 USD | 10.8% |
| 2014 Q2 | -838.72 USD | 6.01% |
| 2014 Q1 | -892.32 USD | 20.22% |
| 2014 Q4 | -781.74 USD | -4.49% |
| 2013 Q4 | -1118.42 USD | -85.46% |
| 2013 FY | -2.73 Million USD | -4.79% |
| 2013 Q2 | -573.49 USD | -18.09% |
| 2013 Q1 | -485.61 USD | -10.26% |
| 2013 Q3 | -603.06 USD | -5.16% |
| 2012 FY | -2.6 Million USD | 0.0% |
| 2012 Q4 | -440.43 USD | 36.81% |
| 2012 Q2 | -762.18 USD | 0.0% |
| 2012 Q3 | -696.95 USD | 8.56% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -50.147% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 71.285% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 103.785% |
| Nascent Biotech, Inc. | -2.08 Million USD | 3.955% |
| Rebus Holdings, Inc. | -1.02 Million USD | -96.58% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 103.078% |
| Qrons Inc. | -789.34 Thousand USD | -154.022% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -217.061% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 96.797% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -382.603% |
| Skye Bioscience, Inc. | -37.64 Million USD | 94.674% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 97.325% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 69.509% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -633.394% |
| SQZ Biotechnologies Company | -79.46 Million USD | 97.477% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 30.676% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -10.139% |
| Mesoblast Limited | -87.95 Million USD | 97.72% |
| Marizyme, Inc. | -65.34 Million USD | 96.932% |
| Genus plc | 7.9 Million USD | 125.381% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 81.591% |
| Pharming Group N.V. | -10.54 Million USD | 80.991% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 7.59% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 45.957% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 77.328% |
| ContraFect Corporation | -65.15 Million USD | 96.922% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 58.963% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -16.073% |
| IMV Inc. | -36.48 Million USD | 94.504% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 75.122% |
| MultiCell Technologies, Inc. | -380.07 USD | -527464.659% |
| ONE Bio Corp. | 8.67 Million USD | 123.109% |
| Accustem Sciences Inc. | -3.74 Million USD | 46.479% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 96.121% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -58.24% |
| Q BioMed Inc. | -2.05 Million USD | 2.289% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 46.287% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 15.782% |
| Biomind Labs Inc. | -1.21 Million USD | -65.123% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 96.643% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 35.356% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 74.629% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -2.866% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -13288.856% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 87.367% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 65.532% |
| GB Sciences, Inc. | -1.36 Million USD | -47.253% |
| Alpha Cognition Inc. | -13.77 Million USD | 85.441% |
| HST Global, Inc. | -146.21 Thousand USD | -1271.394% |
| CSL Limited | 2.64 Billion USD | 100.076% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -14.266% |
| Halberd Corporation | -79.67 Thousand USD | -2416.586% |
| Enzolytics Inc. | -2.17 Million USD | 7.888% |
| Agentix Corp. | -1.37 Million USD | -45.91% |
| Resverlogix Corp. | -3.61 Million USD | 44.457% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 36.776% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.32% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 2146.036% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 128.956% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 49.531% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 33.74% |
| AVAX Technologies, Inc. | -6.41 Million USD | 68.737% |
| Zenith Capital Corp. | -10.59 Million USD | 81.077% |
| Genscript Biotech Corporation | -95.47 Million USD | 97.9% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -8527.119% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 51.637% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -3217.496% |
| Kadimastem Ltd | -3.3 Million USD | 39.375% |
| Helix BioMedix, Inc. | -1.05 Million USD | -89.868% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 47.496% |
| BioStem Technologies, Inc. | -8.48 Million USD | 76.363% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -354.294% |
| LadRx Corporation | 400.44 Thousand USD | 600.724% |
| Cell Source, Inc. | -5.32 Million USD | 62.318% |
| Regen BioPharma, Inc. | 1.02 Million USD | 295.906% |
| Regen BioPharma, Inc. | 1.02 Million USD | 295.906% |
| NovAccess Global Inc. | -4.76 Million USD | 57.957% |
| Affymax, Inc. | -14.42 Million USD | 86.099% |
| Itoco Inc. | -1.86 Million USD | -7.283% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 54.866% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -20.139% |
| Mobile Lads Corp. | -2.26 Million USD | 11.407% |
| CytoDyn Inc. | -49.84 Million USD | 95.977% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -2437.06% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -778.947% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -112.964% |
| SYBLEU INC | -180.3 Thousand USD | -1012.075% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -24.33% |
| International Stem Cell Corporation | -131 Thousand USD | -1430.622% |
| Bioxytran, Inc. | -4.28 Million USD | 53.152% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -3594.566% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 20.754% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 95.829% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 5.151% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -156.774% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 36.707% |
| Neutra Corp. | -233.46 Thousand USD | -758.85% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 90.118% |
| PureTech Health plc | -65.69 Million USD | 96.948% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 90.572% |
| IXICO plc | -1.17 Million USD | -70.213% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 79.801% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 96.49% |
| CSL Limited | 2.64 Billion USD | 100.076% |
| Cellectis S.A. | -103.17 Million USD | 98.057% |